hereditary transthyretin amyloidosisgenetic liver diseasesrare diseasesnon-human primatessmall interfering RNA treatmentsLipid nanoparticle-mRNA therapeuticsRNA-based therapeuticsGalNAc conjugation
…r diseases, exemplified by small interfering RNA treatments for hereditary transthyretin amyloidosis, which use liver-targeting strategies such as GalNAc conjugatio…